Trial Profile
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE SAFETY AND EFFICACY OF VIOKASE® 16 FOR THE CORRECTION OF STEATORRHEA IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Pancrelipase (Primary)
- Indications Pancreatic disorders; Steatorrhoea
- Focus Therapeutic Use
- Sponsors Adare Pharmaceuticals
- 28 Feb 2017 New trial record